Growing evidence suggest that decreases in BDNF content and defects in its signaling pathway via its receptor, TrkB, are associated with neurodegeneration and the progression of Alzheimer’s disease (MacPherson, 2017). Here, NTRK2 is linked to Alzheimer disease.